| Ang II | Angiotensin II |
| α-SMA | Alpha-smooth muscle actin |
| CKD | Chronic kidney disease |
| CTGF | Connective tissue growth factor |
| ECM | Extracellular matrix |
| EMT | Epithelial-mesenchymal transition |
| ESRD | End stage renal disease |
| FGF23 | Fibroblast growth factor23 |
| H2O2 | Hydrogen peroxide |
| IFN-γ | Interferon-γ |
| IL-6 | Interleukin-6 |
| iNOS | Inducible nitric oxide synthase |
| IPF | Idiopathic pulmonary fibrosis |
| LAP | Latency-associated peptide |
| LTBP | Latent TGF-β binding protein |
| MCP-1 | Monocyte chemoattractant protein |
| NF-κB | Nuclear factor kappa B |
| PAI1 | Plasminogen activator inhibitor-1 |
| RAAS | Renin–angiotensin–aldosterone system |
| RNS | reactive nitrogen species |
| ROS | Reactive oxygen species |
| TBR | TGF-β1 receptors |
| TGF-β1 | Transforming growth factor β1 |
| TIMP-1 | Tissue inhibitor of metalloproteinase-1 |
| TNF-α | Tumor necrosis factor-alpha |
| MMPs | Matrix metalloproteinases |
| OPN | Osteopontin |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.